PUBLICATION

Establishment of a drug evaluation model against light-induced retinal degeneration using adult pigmented zebrafish

Authors
Saito, Y., Tsuruma, K., Shimazawa, M., Nishimura, Y., Tanaka, T., Hara, H.
ID
ZDB-PUB-160721-6
Date
2016
Source
Journal of Pharmacological Sciences   131(3): 215-8 (Journal)
Registered Authors
Tanaka, Toshio
Keywords
Dry age-related macular degeneration, Pigmented retina, Zebrafish
MeSH Terms
  • Animals
  • Light*
  • Administration, Ophthalmic
  • Macular Degeneration/drug therapy*
  • Macular Degeneration/etiology
  • Zebrafish
  • Disease Models, Animal*
  • Vitreous Body
  • Acetylcysteine/administration & dosage
  • Acetylcysteine/therapeutic use*
(all 10)
PubMed
27430989 Full text @ J. Pharmacol. Sci.
Abstract
Age-related macular degeneration (AMD) is a major cause of irreversible loss of central vision in the elderly. Zebrafish is an attractive animal model in some respects, lower cost, smaller housing facilities and easier genetic manipulation compared to rodents. The present study aimed to establish a drug evaluation method against light irradiation, as a dry AMD disease model, using adult pigmented zebrafish. Intravitreal administration of an antioxidant, N-acetylcysteine, protected against light-induced retinal degeneration in a concentration-dependent manner. We established a new drug evaluation model against light-induced retinal degeneration that can provide new knowledge about dry AMD pathology and therapy.
Genes / Markers
Figures
Figure Gallery (4 images)
Show all Figures
Expression
Phenotype
Mutations / Transgenics
No data available
Human Disease / Model
Human Disease Fish Conditions Evidence
macular degenerationWTconstant lightTAS
1 - 1 of 1
Show
Sequence Targeting Reagents
No data available
Fish
Fish
WT
1 - 1 of 1
Show
Antibodies
Orthology
No data available
Engineered Foreign Genes
No data available
Mapping
No data available